95849-02-8

Basic information

• Product Name: (AZETIDIN-3-YL)METHANOL
• Synonyms: (AZETIDIN-3-YL)METHANOL;3-(Hydroxymethyl)azetidine;3-(Hydroxymethyl)azetidin...;3-AzetidineMethanol;azetidine-3-yl Methanol
• CAS NO: 95849-02-8
• Molecular Formula: C₄H₉NO
• Molecular Weight: 87.12036
• Mol File: 95849-02-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 154℃
• Flash Point: 86℃
• Appearance: /
• Density: 1.017
• Vapor Pressure: 1.207mmHg at 25°C
• Refractive Index: 1.459
• PKA: 14.82±0.10(Predicted)
• CAS DataBase Reference: (AZETIDIN-3-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (AZETIDIN-3-YL)METHANOL(95849-02-8)
• EPA Substance Registry System: (AZETIDIN-3-YL)METHANOL(95849-02-8)

Safety Data

• Hazardous Substances Data: 95849-02-8(Hazardous Substances Data)

Usage

General Description

(AZETIDIN-3-YL)METHANOL, also known as 3-Hydroxymethyl-azetidine, is a chemical compound with the molecular formula C5H11NO. It is a four-membered nitrogen-containing heterocycle with a hydroxymethyl group attached to the nitrogen atom. (AZETIDIN-3-YL)METHANOL is often used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also used in organic chemistry as a building block for the production of other complex molecules. (AZETIDIN-3-YL)METHANOL has potential applications in the development of new drugs and is an important chemical in the field of medicinal chemistry and drug discovery.

InChI:InChI=1/C4H9NO/c6-3-4-1-5-2-4/h4-6H,1-3H2

Upstream product

• 72351-36-1 1-diphenylmethyl-3-hydroxymethylazetidine 
• 99025-94-2 (1-benzylazetidin-3-yl)methanol 
• 142253-56-3 3-hydroxymethyl-azetidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 948894-45-9 {1-[3-(2-phenylethoxy)propanoyl]azetidin-3-yl}methanol 
• 1046469-05-9 1-{[(8S)-2,3-dimethyl-8-(2-methylphenyl)-3,6,7,8-tetrahydrochromeno[7,8-d]imidazol-5-yl]carbonyl}-azetidin-3-ylmethanol 
• 142253-56-3 3-hydroxymethyl-azetidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers

Retinol-binding protein 4 (RBP4) is a potential drug target for metabolic and ophthalmologic diseases. A high-throughput screening of our compound library has identified a small-molecule RBP4 reducer 7a, as a hit compound. Aiming to provide a suitable too

Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases

N-Ribosyl phosphorylases and hydrolases catalyze nucleophilic displacement reactions by migration of the cationic ribooxacarbenium carbon from the fixed purine to phosphate and water nucleophiles, respectively. As the lysis reaction progresses along the r

Indolobenzazepine HCV NS5B inhibitors

The invention encompasses compounds and salts of Formulas I, II, III, and IV as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.